氨酸蛋白酶的有机亚酸抑制剂
Giang Thanh Le1, Giovanni Abbenante, Praveen K Madala
1Centre for Drug Design and Development, Institute for Molecular Bioscience, University of Queensland, Brisbane, Qld 4072, Australia.
Journal of the American Chemical Society
|September 21, 2006
概括
研究人员开发了一种新型的囊蛋白酶抑制剂,使用一种不太反应的亚齐多米乙烯组. 这种方法提供了强大的,可逆的抑制,提高了稳定性和类似药物的特性,克服了传统电友抑制剂的有毒副作用.
科学领域:
- 生物化学 生物化学
- 药用化学 医学化学
- 酶学 是一种酶学.
背景情况:
- 囊蛋白酶是人类健康和疾病中的关键酶.
- 传统的抑制剂使用反应性电友,由于与生物醇的相互作用,导致非目标毒性.
研究的目的:
- 开发一种新的,更安全的策略来抑制囊蛋白酶抑制.
- 探索使用一种不太有反应性的亚齐多米乙烯组作为电友核弹头的替代品.
主要方法:
- 设计和合成具有亚齐多米乙烯替代剂的抑制剂.
- 对氨酸蛋白酶的抑制活性的评估,包括caspase-1.
- 在生物醇 (二甲二醇,谷氨) 和水性介质的存在下评估抑制剂的稳定性.
主要成果:
- 获得了强大的,可逆的,具有竞争力的caspase-1抑制 (IC50<10nM).
- 与阿尔代基抑制剂相比,在体外显示出更高的稳定性.
- 展示了可取的类似药物的特征.
- 证实了阿齐德在抑制其他卡斯帕酶和卡塞普辛的多功能性.
结论:
- 亚齐多米乙烯组代表了氨酸蛋白酶抑制剂设计的有价值,不那么有反应性的替代品.
- 这种方法提供了一个有前途的策略,以开发更安全,更有效的蛋白酶抑制剂,降低毒性.
- 证明的多功能性表明,在各种氨酸蛋白酶标中具有广泛的适用性.
相关概念视频
Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...


